CareLit · DOI-Nachweis · Aktuelle Neurologie
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy – Final report
DOI 10.1055/s-2006-953181
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA. Jürgens, H. Pels, A. Glasmacher, H. Schulz, K. Fliessbach, M. Linnebank, M. Vogt-Schaden, H. Reichmann, I.G.H. Schmidt-Wolf, U. Schlegel
ZeitschriftAktuelle Neurologie
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objectives: To evaluate response rate, response duration, overall survival, and toxicity in primary central nervous system lymphoma (PCNSL) after systemic and intraventricular chemotherapy with deferred radiotherapy. Patients and Methods: From 09/1995 to 12/2002, 88 patients with PCNSL (median age 62 years) were enrolled in a pilot/phase II study evaluating chemotherapy without radiotherapy. A high-dose methotrexate…
Zitieren
Zitierempfehlung
A. Jürgens, H. Pels, A. Glasmacher, H. Schulz, K. Fliessbach, M. Linnebank, M. Vogt-Schaden, H. Reichmann, I.G.H. Schmidt-Wolf, U. Schlegel (2006) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy – Final report. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2006-953181
Mit CareLit weiterarbeiten